Study Evaluating the Effect of IMA-638 in Subjects With Persistent Asthma

Completed · Phase 2 · Has a placebo group

Conditions studied: Asthma

In brief

Primary purpose is to assess if IMA-638 is safe and improves asthma in subjects with persistent asthma.

Key facts

Study ID
NCT00425061
Run by
Pfizer
People needed
159
Starts
2007-02-01
Expected to finish
2008-08-01
Last updated by the study team
2015-01-14

Who can join

Age: 18 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.